SCHEMBL5738296

SCHEMBL5738296

CCCCCC(CCC)CC([O])=O

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
GPR84 Q9NQS5 7/20 0.44
CA1 P00915 2/20 0.42
FFAR1 O14842 1/20 0.42
MAPT P10636 1/20 0.41
LCK P06239 1/20 0.41
PPARD Q03181 1/20 0.41
ZDHHC20 Q5W0Z9 1/20 0.41
ZDHHC2 Q9UIJ5 1/20 0.41
CA2 P00918 2/20 0.39
FDPS P14324 1/20 0.39
FFAR4 Q5NUL3 1/20 0.38
ACE2 Q9BYF1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2350195 0.93 LMNA (0.54) LMNAGPR84CA1FFAR1MAPT
SCHEMBL2349537 0.89 CA2 (0.47) LMNAGPR84CA1CA2FDPS
SCHEMBL20490045 0.89 CHRM1 (0.42) GPR84CA1CA2FDPS
SCHEMBL8813695 0.87 CA2 (0.47) LMNAGPR84CA1FFAR1MAPT
SCHEMBL276558 0.83 GPR84 (0.59) LMNAGPR84FFAR1MAPTLCK
SCHEMBL8897025 0.83 LMNA (0.46) LMNAGPR84CA1FFAR1MAPT
SCHEMBL23249652 0.81 GPR84 (0.62) LMNAGPR84FFAR1MAPTLCK
SCHEMBL5879043 0.81 GPR84 (0.62) LMNAGPR84FFAR1MAPTLCK
SCHEMBL5878852 0.81 GPR84 (0.62) LMNAGPR84FFAR1MAPTLCK
SCHEMBL630334 0.81 GPR84 (0.62) LMNAGPR84FFAR1MAPTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636192-A1 3-ALKYLIDENEHYDRAZINO SUBSTITUTED HETEROARYL COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS Nissan Chemical Industries, Ltd. (JP) 2006-03-22 EP disclosed
WO-2004108683-A1 3-ALKYLIDENEHYDRAZINO SUBSTITUTED HETEROARYL COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2004-12-16 WO disclosed